New Lung Cancer Screening Guidelines for Patients Available from NCCN
NCCN has released the NCCN Guidelines for Patients™: Lung Cancer Screening, available free of charge on NCCN.com and NCCN.org. The NCCN Guidelines for Patients™ is a tool to help patients and their caregivers take a more active role in prevention and treatment decisions.
FORT WASHINGTON, PA – The National Comprehensive Cancer Network® (NCCN®), with the support of the NCCN Foundation and Lung Cancer Alliance, announces the latest addition to the library of NCCN Guidelines for Patients™, patient-friendly translations of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®). The NCCN Guidelines for Patients™ for Lung Cancer Screening is now available free of charge at NCCN.org, NCCN.com and LungCancerAlliance.org.
The NCCN Guidelines for Patients™ are designed to provide people with cancer and their caregivers with state-of-the-art treatment and screening information in easy to understand language. According to the Centers for Disease Control and Prevention (CDC), more people die from lung cancer than any other type of cancer, and it is the second most diagnosed cancer in both men and women in the United States. Given the mortality rates, it is critical to provide resources which can empower the public and caregivers to take an active role in disease prevention and treatment decisions.
The NCCN Guidelines for Patients™: Lung Cancer Screening is dedicated to the at-risk public and is supported by Lung Cancer Alliance, a national organization devoted to public health advocacy and to providing reliable information on lung cancer risk, screening, diagnosis, and treatment options since 1995. Each year, Lung Cancer Alliance provides tens of thousands of individuals with comprehensive, tailored information which enables them to make educated decisions throughout their cancer journey.
Lung Cancer Alliance is committed to helping people who are either living with or are at risk for lung cancer. It is a privilege to be collaborating with NCCN on this important, life-saving endeavor , said Laurie Fenton Ambrose, President and CEO of Lung Cancer Alliance.
In announcing the publication of the NCCN Guidelines for Patients™: Lung Cancer Screening, NCCN`s Executive Vice President and Chief Operating Officer Patricia Goldsmith acknowledged the importance of sharing this information with the public. The NCCN Foundation was created to help bring the best treatment guidelines to the public and patients as effectively and quickly as possible, said Ms. Goldsmith. As with our other NCCN Guidelines for Patients, the Lung Cancer Screening guidelines for those at risk for lung cancer were created from the professional version which physicians use when determining appropriate treatment options. With generous support and collaboration from groups such as Lung Cancer Alliance, we can continue to provide authoritative information and recommendations to the public, patients and their families.
The NCCN Guidelines® are developed by multidisciplinary panels of experts from NCCN Member Institutions and feature algorithms or decision trees that address every appropriate management option from initial work-up throughout the course of the disease. The NCCN Guidelines for Patients™ translate these professional guidelines in a clear, step-by-step manner that people can use as the basis for making decisions and discussing treatment options with their physicians.
NCCN offers nine other NCCN Guidelines for Patients™ including Breast, Colon, Non-Small Cell Lung, Ovarian, and Prostate Cancers, Chronic Myelogenous Leukemia, Malignant Pleural Mesothelioma, Melanoma, and Multiple Myeloma. Additional NCCN Guidelines for Patients™ will be available throughout 2012.
Printed copies of the NCCN Guidelines for Patients™: Lung Cancer Screening are available. Please e-mail email@example.com to request your FREE copy.
About the National Comprehensive Cancer Network
The National Comprehensive Cancer Network® (NCCN®), a not-for-profit alliance of 26 of the world's leading cancer centers, is dedicated to improving the quality and effectiveness of care provided to patients with cancer. Through the leadership and expertise of clinical professionals at NCCN Member Institutions, NCCN develops resources that present valuable information to the numerous stakeholders in the health care delivery system. As the arbiter of high-quality cancer care, NCCN promotes the importance of continuous quality improvement and recognizes the significance of creating clinical practice guidelines appropriate for use by patients, clinicians, and other health care decision-makers. The primary goal of all NCCN initiatives is to improve the quality, effectiveness, and efficiency of oncology practice so patients can live better lives. For more information, visit NCCN.org.
The NCCN Member Institutions are:
- Fred & Pamela Buffett Cancer Center
- Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute
- City of Hope Comprehensive Cancer Center
- Dana-Farber/Brigham and Women's Cancer Center
Massachusetts General Hospital Cancer Center
- Duke Cancer Institute
- Fox Chase Cancer Center
- Huntsman Cancer Institute at the University of Utah
- Fred Hutchinson Cancer Research Center / Seattle Cancer Care Alliance
- The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Robert H. Lurie Comprehensive Cancer Center of Northwestern University
- Mayo Clinic Cancer Center
- Memorial Sloan Kettering Cancer Center
- Moffitt Cancer Center
- The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute
- Roswell Park Cancer Institute
- Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine
- St. Jude Children's Research Hospital/The University of Tennessee Health Science Center
- Stanford Cancer Institute
- University of Alabama at Birmingham Comprehensive Cancer Center
- UC San Diego Moores Cancer Center
- UCSF Helen Diller Family Comprehensive Cancer Center
- University of Colorado Cancer Center
- University of Michigan Comprehensive Cancer Center
- The University of Texas MD Anderson Cancer Center
- Vanderbilt-Ingram Cancer Center
- Yale Cancer Center/Smilow Cancer Hospital